The trademark application ULTREON was filed by Abbott Cardiovascular Systems Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 9, 2021, and it was registered by office on August 16, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).